The Effect of Non-surgical Periodontal Therapy on the Gingival Crevicular Fluid Levels of Prolactin Hormone in Patients With Periodontitis.
1 other identifier
interventional
50
1 country
1
Brief Summary
The present study will be conducted on fifty participants. All participants will receive a full-mouth clinical examination, and the following periodontal parameters will be recorded: Plaque Index (PI). Gingival Index (GI), probing depth (PD), and clinical attachment level (CAL). All of these measurements will be recorded at six sites at baseline for all participants and 3 months after non-surgical periodontal therapy for the study group. GCF samples will be collected from the buccal aspects of teeth that had the highest signs of inflammation and attachment loss for periodontitis group at baseline and 3 months after non-surgical periodontal therapy. As for controls, the samples will be collected from buccal aspect of upper first molar at baseline. The samples will be assayed for prolactin by using an enzyme linked immunosorbent assay kits (Elisa) according to the manufacturer instruction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2018
CompletedFirst Posted
Study publicly available on registry
October 31, 2018
CompletedStudy Start
First participant enrolled
November 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2019
CompletedMarch 12, 2019
March 1, 2019
3 months
October 30, 2018
March 9, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
prolactin in GCF
prolactin level in GCF by ELISA
3 months
Study Arms (2)
periodontitis group
EXPERIMENTALin this group, prolactin in GCF will be assessed at baseline and after 3 months of receiving non-surgical periodontal treatment
control group
NO INTERVENTIONin this group of systemically and periodontally healthy participants, prolactin in GCF will be assessed at baseline only
Interventions
Eligibility Criteria
You may qualify if:
- Subjects with moderate to severe chronic periodontitis, with probing pocket depth (PPD) ≥ 4-6 mm and clinical attachment level ≥ 4-5 mm, according to the American Academy of Periodontology.7
- Highly motivated and cooperative patients
You may not qualify if:
- The presence of any systemic disease.
- Taking medications for the last 3 months before conducting this study.
- Pregnancy and lactation.
- Any type of previous periodontal treatment (surgical or non-surgical) in the preceding 6 months.
- Smoking (former or current).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eman Mohamed Amrlead
Study Sites (1)
Faculty of Dentistry
Cairo, 11431, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor of Oral Medicine and Periodontology
Study Record Dates
First Submitted
October 30, 2018
First Posted
October 31, 2018
Study Start
November 1, 2018
Primary Completion
January 31, 2019
Study Completion
February 1, 2019
Last Updated
March 12, 2019
Record last verified: 2019-03